Ameritas Investment Partners, Inc. - SYNERGY PHARMACEUTICALS DEL ownership

SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 147 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q2 2017. The put-call ratio across all filers is 1.11 and the average weighting 0.1%.

Quarter-by-quarter ownership
Ameritas Investment Partners, Inc. ownership history of SYNERGY PHARMACEUTICALS DEL
ValueSharesWeighting
Q4 2018$2,000
-94.1%
19,9060.0%0.00%
-100.0%
Q3 2018$34,000
-2.9%
19,9060.0%0.00%0.0%
Q2 2018$35,000
-2.8%
19,9060.0%0.00%0.0%
Q1 2018$36,000
-18.2%
19,9060.0%0.00%0.0%
Q4 2017$44,000
-25.4%
19,9060.0%0.00%
-33.3%
Q3 2017$59,000
-33.7%
19,9060.0%0.00%
-25.0%
Q2 2017$89,000
+11.2%
19,906
+16.6%
0.00%0.0%
Q1 2017$80,000
-15.8%
17,067
+8.9%
0.00%
-20.0%
Q4 2016$95,000
+10.5%
15,6670.0%0.01%0.0%
Q3 2016$86,000
+59.3%
15,667
+10.8%
0.01%
+25.0%
Q2 2016$54,00014,1370.00%
Other shareholders
SYNERGY PHARMACEUTICALS DEL shareholders Q2 2017
NameSharesValueWeighting ↓
Nantahala Capital Management 11,578,568$20,147,0000.82%
Virtus ETF Advisers LLC 441,461$768,0000.68%
Hikari Power Ltd 2,300,000$4,002,0000.44%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,403,149$2,441,0000.17%
KNOTT DAVID M 225,400$392,0000.15%
Clear Harbor Asset Management, LLC 277,110$482,0000.09%
Malaga Cove Capital, LLC 97,264$169,0000.09%
Lehman Financial Resources, Inc. 80,800$140,0000.07%
Cheyne Capital Management (UK) LLP 50,000$87,0000.06%
Ballew Advisors, Inc 26,200$46,0000.05%
View complete list of SYNERGY PHARMACEUTICALS DEL shareholders